Knowledge is the key to success in the investment business.That’s why HWS will be featuring its own in-house research reports. In this section we will publish CFA coverage of our featured companies, as well as research reports on companies who are attracting major attention in key industry sectors.
EquityNet Research Initiates Independent Research Coverage on Biostar Pharmaceuticals, Inc.
LOS ANGELES – Feb. 18, 2010 — EquityNet Research, an independent West Coast equity research firm, announced today that it has initiated coverage of Biostar Pharmaceuticals, Inc. (OTCBB: BSPM).
A full copy of the report and disclosure requirements are available at EquityNet Research’s Web site: www.equitynet.net.
Biostar is a Xianyang-based developer, manufacturer and supplier of [...]
EquityNet Research Initiates Coverage on Huifeng Biopharmaceutical (OTCBB:HFGB)
LOS ANGELES – Feb. 10, 2010 — EquityNet Research, an independent West Coast equity research firm, announced today that it has initiated coverage on Huifeng Bio-Pharmaceutical Technology, Inc. (OTCBB: HFGB).
A full copy of the report and disclosure requirements are available at EquityNet Research’s Web site: www.equitynet.net.
Huifeng develops, produces and sells [...]
Research Report – SkyPeople Fruit Juice Inc.
“EquityNet Research, a West-Coast independent equity research firm, announced today that it has initiated coverage on the SkyPeople Fruit Juice, Inc. (AMEX:SPU) with a ‘Buy’ recommendation and a 12-month price target of $13.29 per share. SkyPeople, through its subsidiary Shaanxi Tianren Organic Food Co., Ltd., engages in the production and sale of special concentrated [...]
